PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q4 2020. The put-call ratio across all filers is 1.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $149,326 | -13.8% | 140,874 | +23.6% | 0.00% | – |
| Q4 2022 | $173,192 | -27.5% | 113,942 | +0.9% | 0.00% | – |
| Q3 2022 | $239,000 | +59.3% | 112,897 | +0.5% | 0.00% | – |
| Q2 2022 | $150,000 | -38.5% | 112,319 | -2.8% | 0.00% | – |
| Q1 2022 | $244,000 | -41.1% | 115,513 | +3.5% | 0.00% | – |
| Q4 2021 | $414,000 | -23.6% | 111,569 | +2.9% | 0.00% | – |
| Q3 2021 | $542,000 | -20.4% | 108,454 | +3.8% | 0.00% | – |
| Q2 2021 | $681,000 | -7.5% | 104,509 | -2.2% | 0.00% | – |
| Q1 2021 | $736,000 | -53.1% | 106,873 | -30.5% | 0.00% | -100.0% |
| Q4 2020 | $1,569,000 | +167.3% | 153,734 | -8.3% | 0.00% | – |
| Q3 2020 | $587,000 | +24.6% | 167,576 | +77.7% | 0.00% | – |
| Q2 2020 | $471,000 | -8.2% | 94,321 | -37.6% | 0.00% | – |
| Q1 2020 | $513,000 | – | 151,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |